Kari Harno
Overview
Explore the profile of Kari Harno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
239
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liedes H, Pajula J, Vuorinen A, De Pretis F, van Gils M, Harno K, et al.
Basic Clin Pharmacol Toxicol
. 2023 May;
133(2):202-207.
PMID: 37162098
No abstract available.
2.
Lahteenmaki J, Vuorinen A, Pajula J, Harno K, Lehto M, Niemi M, et al.
Clin Pharmacol Ther
. 2021 May;
110(3):768-776.
PMID: 34043814
This study aimed to analyze associations between genetic variants and the occurrence of clinical outcomes in dabigatran, apixaban, and rivaroxaban users. This was a retrospective real-world study linking genotype data...
3.
Lahteenmaki J, Vuorinen A, Pajula J, Harno K, Lehto M, Niemi M, et al.
Scand J Public Health
. 2021 Apr;
50(4):482-489.
PMID: 33845693
This case study aimed to investigate the process of integrating resources of multiple biobanks and health-care registers, especially addressing data permit application, time schedules, co-operation of stakeholders, data exchange and...
4.
Vuorinen A, Lehto M, Niemi M, Harno K, Pajula J, van Gils M, et al.
Clin Epidemiol
. 2021 Mar;
13:183-195.
PMID: 33727862
Purpose: To assess the association between and variants and the incidence of adverse drug reactions in warfarin-treated patients in a real-world setting. Materials And Methods: This was a register-based cohort...
5.
Schnell O, Alawi H, Battelino T, Ceriello A, Diem P, Felton A, et al.
J Diabetes Sci Technol
. 2014 May;
8(4):783-90.
PMID: 24876442
The role for the novel treatment approach of sodium-glucose cotransporter-2 (SGLT-2) in type 2 diabetes is increasing. Structured self-monitoring of blood glucose (SMBG), based on a less intensive and a...
6.
Orsama A, Lahteenmaki J, Harno K, Kulju M, Wintergerst E, Schachner H, et al.
Diabetes Technol Ther
. 2013 Jul;
15(8):662-9.
PMID: 23844570
Background: Type 2 diabetes is an individual health challenge requiring ongoing self-management. Remote patient reporting of relevant health parameters and linked automated feedback via mobile telephone have potential to strengthen...
7.
Schnell O, Alawi H, Battelino T, Ceriello A, Diem P, Felton A, et al.
J Diabetes Sci Technol
. 2013 Apr;
7(2):478-88.
PMID: 23567007
The increasing role for structured and personalized self-monitoring of blood glucose (SMBG) in management of type 2 diabetes has been underlined by randomized and prospective clinical trials. These include Structured...
8.
Ceriello A, Barkai L, Christiansen J, Czupryniak L, Gomis R, Harno K, et al.
Diabetes Res Clin Pract
. 2012 Aug;
98(1):5-10.
PMID: 22917639
As non-communicable or chronic diseases are a growing threat to human health and economic growth, political stakeholders are aiming to identify options for improved response to the challenges of prevention...
9.
Schnell O, Alawi H, Battelino T, Ceriello A, Diem P, Felton A, et al.
J Diabetes Sci Technol
. 2012 Jul;
6(3):665-73.
PMID: 22768899
The role of glucagon-like peptide (GLP)-1-based treatment approaches for type 2 diabetes mellitus (T2DM) is increasing. Although self-monitoring of blood glucose (SMBG) has been performed in numerous studies on GLP-1...
10.
Patja K, Absetz P, Auvinen A, Tokola K, Kyto J, Oksman E, et al.
BMC Health Serv Res
. 2012 Jun;
12:147.
PMID: 22682298
Background: The aim was to evaluate the effect of a 12-month individualized health coaching intervention by telephony on clinical outcomes. Methods: An open-label cluster-randomized parallel groups trial. Pre- and post-intervention...